TherapeuticsMD, Inc. (TXMD)

NASDAQ: TXMD · IEX Real-Time Price · USD
1.885
-0.015 (-0.79%)
Apr 19, 2024, 2:01 PM EDT - Market open
-0.79%
Market Cap 21.74M
Revenue (ttm) 1.30M
Net Income (ttm) -10.28M
Shares Out 11.53M
EPS (ttm) -0.98
PE Ratio n/a
Forward PE 2.29
Dividend n/a
Ex-Dividend Date n/a
Volume 8,384
Open 1.880
Previous Close 1.900
Day's Range 1.880 - 1.982
52-Week Range 1.860 - 4.720
Beta 1.04
Analysts Hold
Price Target 5.00 (+165.25%)
Earnings Date May 13, 2024

About TXMD

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida. [Read more]

Sector Healthcare
CEO Marlan D. Walker J.D.
Employees 1
Stock Exchange NASDAQ
Ticker Symbol TXMD
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for TXMD stock is "Hold" and the 12-month stock price forecast is $5.0.

Price Target
$5.0
(165.25% upside)
Analyst Consensus: Hold
Stock Forecasts

News

TherapeuticsMD Announces Full Year 2023 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for...

20 days ago - Business Wire

TherapeuticsMD Announces Third Quarter 2023 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for...

5 months ago - Business Wire

TherapeuticsMD Announces Second Quarter 2023 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for...

8 months ago - Business Wire

TherapeuticsMD Announces First Quarter 2023 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for...

1 year ago - Business Wire

TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for...

1 year ago - Business Wire

TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or the “Company”), an innovative, leading women's healthcare company, today announced that it has com...

1 year ago - Business Wire

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or the “Company”), an innovative, leading women's healthcare company, today announced that it has ent...

1 year ago - Business Wire

TherapeuticsMD Announces Third Quarter 2022 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today reported financial results for the third qu...

1 year ago - Business Wire

TherapeuticsMD Announces Additional $7 Million Private Placement

BOCA RATON, Fla.

1 year ago - Business Wire

TherapeuticsMD Announces $7 Million Private Placement

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), (“TherapeuticsMD” or the “Company”) an innovative, leading women's healthcare company, announced today that it received a $7 mil...

1 year ago - Business Wire

TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), (“TherapeuticsMD” or the “Company”) an innovative, leading women's healthcare company, announced today the appointment of Dr. Br...

1 year ago - Business Wire

TherapeuticsMD Announces Second Quarter 2022 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today reported financial results for the Second Qua...

1 year ago - Business Wire

TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that it will report its second quar...

1 year ago - Business Wire

TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), (“TherapeuticsMD” or the “Company”) an innovative, leading women's healthcare company, announced today that it has received a $1...

1 year ago - Business Wire

Why TherapeuticsMD Shares Are Sinking Today?

Women's healthcare company TherapeuticsMD Inc (NASDAQ: TXMD) shares are falling as EW Healthcare Partners did not acquire the required majority of shares of TXMD through the previously announced tende...

1 year ago - Benzinga

TherapeuticsMD's stock falls 41% after tender offer expires

Shares of TherapeuticsMD Inc. TXMD, +8.67% tumbled 41.6% in premarket trading on Wednesday after the women's health company told investors that EW Healthcare Partners' planned acquisition of Therapeut...

1 year ago - Market Watch

TherapeuticsMD Announces Expiration of Tender Offer

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), (“TXMD” or the “Company”) an innovative, leading women's healthcare company, announced today that Athene Merger, Inc., an affili...

1 year ago - Business Wire

EW Healthcare Partners Announces Extension of TherapeuticsMD Tender Offer

TherapeuticsMD has previously stated that absent the successful closing of this transaction, the Company would likely be required to file for protection under Chapter 11. BOCA RATON, Fla.

1 year ago - PRNewsWire

5 Short Squeeze Candidates To Watch This Week: Revlon Tops The List, A SPAC Shifts To Second And More

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

Other symbols: ELYMWEBR
1 year ago - Benzinga

5 Short Squeeze Candidates To Watch This Week: TherapeuticsMD Tops List While This Arts And Crafts Retailer Joins The Leaderboard

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

Other symbols: BEEMELYM
2 years ago - Benzinga

EW Healthcare Partners Announces Commencement of the Tender Offer for All Outstanding Shares of TherapeuticsMD

NEW YORK , June 6, 2022 /PRNewswire/ -- EW Healthcare Partners (together with its consolidated subsidiaries and affiliates "EW") announced today that its affiliate, Athene Merger Sub, Inc. ("Purchaser...

2 years ago - PRNewsWire

Investor Alert - The M&A Class Action Firm Announces an Investigation of TherapeuticsMD, Inc. - TXMD

NEW YORK , June 1, 2022 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rat...

2 years ago - PRNewsWire

THERAPEUTICSMD INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TherapeuticsMD, Inc. - TXMD

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of TherapeuticsMD, ...

2 years ago - Business Wire

SHAREHOLDER ALERT: Weiss Law Investigates TherapeuticsMD, Inc.

NEW YORK , May 31, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of TherapeuticsMD, Inc. ("TherapeuticsMD" o...

2 years ago - PRNewsWire

Here is why TherapeuticsMD jumped 300%

TherapeuticsMD Inc. (NASDAQ: TXMD) surged 300% after the women's healthcare firm announced the signing of a definitive agreement to be purchased by an EW Healthcare Partners affiliate. EW Healthcare P...

2 years ago - Invezz